Scientists suggest that drugs similar to Ozempic may be rewiring the brain’s reward pathways, decreasing the release of dopamine from addictive substances (Representational image: Insulin pen)|Heather Aitken|CC BY-SA 2.0
Apart from reducing weight, the diabetes drug Ozempic has shown potential as an appetite suppressant for addictive habits, such as drinking and smoking, according to recent sources.
After starting the medication, some patients have reported a decrease in interest in activities such as excessive drinking, compulsive shopping, nail biting and skin picking.
Scientists suggest that drugs similar to Ozempic may be rewiring the brain’s reward pathways, decreasing the release of dopamine from addictive substances.
Although much of the evidence remains anecdotal, clinical trials are underway to investigate whether Ozempic can be officially recognized as an effective treatment for addiction.